PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11744714-8	2002	12-O-Tetradecanoyl phorbol 13-acetate (16 nm), a PKC activator, reproduced the effects of gp160 in untreated cells.	Tetradecanoylphorbol Acetate	0-37	glutamyl aminopeptidase	Homo sapiens	90-95	
17869664-8	2007	The estimated brachytherapy doses delivered to the APA as a percentage of the presumed 500-cGy fraction size to the TPA were 35.2% (176.6 +/- 59.0 cGy) on the right and 30.0% (150.2 +/- 42.9 cGy) on the left.	Tetradecanoylphorbol Acetate	116-119	glutamyl aminopeptidase	Homo sapiens	51-54	
9045910-6	1997	Pre-incubation of CD4+ T lymphocytes in the presence of anti-CD4 mAb or gp160 inhibits the activation of JNK in response to phorbol 12-myristate 13-acetate and ionomycin.	Tetradecanoylphorbol Acetate	124-155	glutamyl aminopeptidase	Homo sapiens	72-77	
10432309-5	1999	Our simulations show that there are significant differences in structure between the TpA step (where p=phosphate) and the ApA and ApT steps, where a large roll into the major groove at the TpA step appears to be an important factor in widening the minor groove at this position.	Tetradecanoylphorbol Acetate	189-192	glutamyl aminopeptidase	Homo sapiens	122-125